Alzheimer’s Patient Groups Protest Medicare’s Proposal to Limit Coverage of New Drugs

Published on January 21, 2022

Alzheimer’s patient groups, disappointed by Medicare’s plan to sharply limit coverage of new drugs for the brain-wasting disease, are planning publicity and lobbying campaigns to protest a proposal they say could delay their use for 10 years. “Congress has to know how bad…

Read Full Article (External Site)